EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Equine autologous blood-based products contain variable quantities of transforming growth factor-β1, interleukin-1 receptor antagonist, and α2-macroglobulin

Dhvani Barot, Alexandra Usimaki, Renata L Linardi, Charles M Arensberg, Kyla F Ortved iD

American Journal of Veterinary Research · 01.04.2025 · 86 (4)

DOI: 10.2460/ajvr.24.11.0363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 01.04.2025. Verfasst von Dhvani Barot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Studies-New Bolton Center, University of Pennsylvania, Kennett Square, PA. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Interleukin 1 Receptor Antagonist Protein, alpha-Macroglobulins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Quantify the concentration of α 2 -macroglobulin (A2M), immunomodulatory cytokines, and TGF-β1 factors in 4 commercially available autologous blood-based products including conditioned A2M (CA2M; Alpha2EQ; Astaria Global), autologous protein solution (APS; Pro-Stride; Zoetis), platelet-rich plasma (PRP; Restigen; Zoetis), and autologous conditioned plasma (ACP; Arthrex ACP). We hypothesized that CA2M would have higher concentrations of A2M and lower concentrations of cytokines and growth factors compared to APS, PRP, and ACP.

Methods

Blood was obtained from 6 healthy, adult horses and processed into CA2M, APS, PRP, and ACP. The concentration of immunomodulatory cytokines, including IL-1β, IL-4, IL-6, IL-10, IL-17a, and TNF-α, and the concentration of the growth factor TGF-β1 were quantified using immunoassays. The concentration of the IL-1 receptor antagonist was quantified using ELISA. The concentration of A2M was quantified using mass spectrometry.

Results

No differences in the concentrations of IL-1β, IL-4, IL-6, IL-10, and IL-17a were found. Median TGF-β1 was significantly higher in APS (10,801 pg/mL; P < .05), PRP (6,219 pg/mL; P < .05), and ACP (5,263 pg/mL; P < .05) compared to CA2M (2,090 pg/mL). The IL-1 receptor antagonist was significantly higher in APS (58.78 ng/mL) and PRP (40.45 ng/mL). Median A2M concentration was significantly higher in APS (4.08 mg/mL; P < .001) compared to CA2M (1.99 mg/mL).

Conclusions

Autologous blood-based products have notably different immunomodulatory and growth factor profiles. These differences likely reflect variable concentrations of platelets and WBCs, as well as processing methods. Clinical Relevance Equine veterinarians should be aware of the constituents of the different orthobiologics available before use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta1Interleukin 1 Receptor Antagonist Proteinalpha-MacroglobulinsAnimalsHorsesCytokinesPlatelet-Rich PlasmaMaleFemaleBlood Transfusion, Autologous

Stichwörter der Autor:innen

autologous conditioned plasmaautologous protein solutionplatelet-rich plasmaregenerative medicineα2 macroglobulin (A2M)

Substanzen

Transforming Growth Factor beta1Interleukin 1 Receptor Antagonist Proteinalpha-MacroglobulinsCytokines

Autor:innen und Institutionen

  • Department of Clinical Studies-New Bolton Center, University of Pennsylvania, Kennett Square, PA.
  • Bessemer Equine, Kennett Square, PA.

ORCID-Profile: Kyla F Ortved

Zitieren

APA

Barot, D., Usimaki, A., Linardi, R. L., Arensberg, C. M., & Ortved, K. F. (2025). Equine autologous blood-based products contain variable quantities of transforming growth factor-β1, interleukin-1 receptor antagonist, and α2-macroglobulin. American Journal of Veterinary Research, 86(4). https://doi.org/10.2460/ajvr.24.11.0363

Vancouver

Barot D, Usimaki A, Linardi RL, Arensberg CM, Ortved KF. Equine autologous blood-based products contain variable quantities of transforming growth factor-β1, interleukin-1 receptor antagonist, and α2-macroglobulin. American Journal of Veterinary Research. 2025;86(4). doi:10.2460/ajvr.24.11.0363

BibTeX
@article{Barot2025,
  author = {Barot, Dhvani and Usimaki, Alexandra and Linardi, Renata L and Arensberg, Charles M and Ortved, Kyla F},
  title = {Equine autologous blood-based products contain variable quantities of transforming growth factor-β1, interleukin-1 receptor antagonist, and α2-macroglobulin},
  journal = {American Journal of Veterinary Research},
  year = {2025},
  volume = {86},
  number = {4},
  doi = {10.2460/ajvr.24.11.0363}
}
Kostenlos starten →